Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

TherapeuticsMD Inc (TXMD)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow TherapeuticsMD's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
TherapeuticsMD historical data, for real-time data please try another search
5.45 +0.34    +6.65%
13/01 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
ISIN:  US88338N2062 
CUSIP:  88338N206
  • Volume: 109
  • Bid/Ask: 5.37 / 5.38
  • Day's Range: 5.45 - 5.45
TherapeuticsMD 5.45 +0.34 +6.65%

TXMD Recent Sentiments

 
This page contains information on users’ sentiments for the TherapeuticsMD Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Apr 10, 2024 Gianluca Montemezzo   2.09 May 03, 2024 @ 1.88 -10.05%
Feb 05, 2024 Ivan Sakal   2.28 Mar 01, 2024 @ 2.54 -11.23%
Dec 18, 2023 Andrea Molina   2.34 Jan 12, 2024 @ 2.28 -2.56%
Nov 01, 2023 Andrea Molina   2.12 Nov 30, 2023 @ 2.79 +31.91%
Oct 23, 2023 Gianluca Montemezzo   2.17 Nov 30, 2023 @ 2.79 +28.28%
Jun 07, 2023 Geva Biadgo   4.01 Nov 30, 2023 @ 2.79 -30.51%
May 12, 2023 Robbert Kuipers   4.47 May 12, 2023 @ 4.44 -0.67%
Mar 31, 2023 Michael Bygodt   3.66 Apr 21, 2023 @ 3.74 +2.19%
Mar 28, 2023 Thibaud Jacob   3.57 Apr 03, 2023 @ 3.72 -4.17%
Mar 14, 2023 Geva Biadgo   4.00 Apr 07, 2023 @ 3.56 -11.11%
Jan 31, 2023 Geva Biadgo   5.27 Feb 24, 2023 @ 4.99 -5.31%
Jan 06, 2023 Geva Biadgo   5.69 Jan 27, 2023 @ 5.34 -6.15%
Dec 28, 2022 Gianluca Montemezzo   5.59 Jan 20, 2023 @ 5.49 -1.79%
Dec 21, 2022 Mathieu Dedon   6.18 Dec 21, 2022 @ 6.18 0.00%
Dec 07, 2022 Robbert Kuipers   6.04 Dec 30, 2022 @ 5.59 -7.45%
Dec 07, 2022 Robbert Kuipers   6.04 Dec 07, 2022 @ 6.04 0.00%
Dec 07, 2022 Carmine Allocca   5.22 Dec 30, 2022 @ 5.59 +7.09%
Dec 05, 2022 Robbert Kuipers   5.71 Dec 30, 2022 @ 5.59 -2.10%
Dec 05, 2022 Robbert Kuipers   5.55 Dec 05, 2022 @ 5.71 +2.88%
Dec 05, 2022 Robbert Kuipers   5.55 Dec 05, 2022 @ 5.55 0.00%
Dec 05, 2022 Simone Atzori   5.00 Dec 30, 2022 @ 5.59 +11.80%
Dec 05, 2022 Aziz Nigmatov   4.74 Dec 05, 2022 @ 4.74 +0.11%
Dec 05, 2022 Michael Bygodt   4.84 Dec 30, 2022 @ 5.59 +15.50%
Nov 15, 2022 Roman Guta   5.87 Dec 09, 2022 @ 6.42 +9.37%
Oct 26, 2022 Thibaud Jacob   6.44 Nov 18, 2022 @ 5.04 -21.74%
Oct 26, 2022 Димитър Димитров   6.27 Nov 18, 2022 @ 5.04 +19.59%
Sep 27, 2022 Geva Biadgo   7.32 Oct 21, 2022 @ 6.37 -13.00%
Sep 06, 2022 Gianluca Montemezzo   8.10 Sep 30, 2022 @ 6.64 -18.02%
Sep 06, 2022 Andreas Schatz   8.09 Sep 30, 2022 @ 6.64 -17.89%
Aug 24, 2022 Roman Guta   9.33 Sep 16, 2022 @ 7.98 -14.51%
Aug 15, 2022 David Acuña   11.38 Sep 09, 2022 @ 8.47 -25.57%
Aug 15, 2022 Geva Biadgo   10.83 Sep 09, 2022 @ 8.47 -21.79%
Aug 02, 2022 Michael Bygodt   8.49 Aug 26, 2022 @ 9.13 +7.54%
Aug 01, 2022 Domas Pavasarinis   7.67 Aug 08, 2022 @ 9.37 +22.16%
Jul 14, 2022 glen jabalee   4.65 Jul 18, 2022 @ 5.68 +22.15%
Jul 13, 2022 רונן בן   5.17 Aug 05, 2022 @ 9.29 +79.69%
Jul 13, 2022 sunil middha   4.37 Jul 18, 2022 @ 5.70 +30.48%
Jul 11, 2022 Gianluca Montemezzo   8.08 Aug 05, 2022 @ 9.29 +14.98%
Jul 08, 2022 Geva Biadgo   9.73 Jul 29, 2022 @ 6.23 -35.98%
Jun 29, 2022 stephane paquin   9.93 Jul 22, 2022 @ 5.57 -43.88%
Jun 07, 2022 Romeo Petcu   10.01 Jul 01, 2022 @ 9.96 -0.50%
Jun 02, 2022 Simone Atzori   9.95 Jun 24, 2022 @ 9.90 +0.50%
Jun 01, 2022 Alpha Alpha   9.90 Jun 24, 2022 @ 9.90 -0.01%
May 31, 2022 Monica Ascari   9.89 Jun 24, 2022 @ 9.90 +0.10%
May 31, 2022 Humberto Ochoa   9.88 Jun 10, 2022 @ 9.91 -0.25%
May 31, 2022 daimy raver   9.88 Jun 24, 2022 @ 9.90 -0.15%
May 31, 2022 Hugo Batista   9.88 Jun 24, 2022 @ 9.90 -0.20%
May 31, 2022 Geva Biadgo   9.89 Jun 24, 2022 @ 9.90 +0.10%
May 31, 2022 osama ss   9.77 Jun 24, 2022 @ 9.90 +1.38%
May 31, 2022 תמיר תמיר   9.86 Jun 24, 2022 @ 9.90 +0.41%
More
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

TXMD Comments

Write your thoughts about TherapeuticsMD Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Darion Lane
Darion Lane Jun 26, 2022 1:49PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What happened to this company to make it fall so much?
Reply
0 0
Report
Liviu Chirita
Liviu Chirita May 31, 2022 10:55AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
this share should be 100$ so that i gain back my loses. still long way but you never know
Reply
1 0
Report
Feras Jarwan
Feras Jarwan May 31, 2022 10:55AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Me too, need 120 to back my loses
Reply
0 0
Report
Ruslan Shevchuk
Ruslan Shevchuk May 31, 2022 6:28AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What happened?plus 353% on pre market, is it a joke?
Reply
0 0
Report
AI Kanak
AIKanak May 31, 2022 6:28AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
No it merged with a huge heath comany which boughtits share at $10.00 per sahre.
Reply
2 0
Report
Ruslan Shevchuk
Ruslan Shevchuk May 31, 2022 6:28AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
is it mean that I never will see 90$ I spent per share?how is proceed regularly?Cost limit with 10$, am I right?
Reply
0 0
Report
May 10, 2022 11:18AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Someone need to investigate this company - from 7.5$ to 3.8$ in one day after a split?
Reply
1 0
Report
May 10, 2022 11:14AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
From 0.15$ to 7.5$ and back to 0.15$ just with less stocks
Reply
0 0
Report
Aidas Sulcas
Aidas Sulcas May 09, 2022 5:10PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
from 1800 shares left 36..... totally.......
Reply
0 0
Report
Real Analyst
Real Analyst May 09, 2022 10:25AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
this is bad
Reply
0 0
Report
May 09, 2022 9:40AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This is fraud!!!
Reply
1 0
Report
May 09, 2022 9:40AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Split 1 to 50 and 30% cut off???
Reply
0 0
Report
Real Analyst
Real Analyst May 09, 2022 9:40AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
definitely yes
Reply
0 0
Report
Momo HD
Momo HD May 09, 2022 9:16AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
can I have +4.000 % aswell please
Reply
0 0
Report
alex Kur
alex Kur May 09, 2022 7:02AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
what is this premarket gains?? scam??
Reply
2 0
Report
Jay Friedman
Jay Friedman May 09, 2022 7:02AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
reverse split 1 share per 50
Reply
1 0
Report
alex Kur
alex Kur May 09, 2022 7:02AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Jay Friedman explain plz
Reply
0 0
Report
May 09, 2022 7:02AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
alex Kur look it up or stop trading
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email